Unlocking the Complexity of Disease with Transomics and AI

A compelling exploration of transomics and AI in drug discovery with Pepper Bio’s CSO, Dr. Samantha Dale Strasser, on the Life Sciences DNA Podcast. Delve into the challenges and strategies in tackling intractable diseases, the integration of omics data, and the journey towards revolutionary patient outcomes with hosts Daniel Levine and Dr. Amar Drawid. Discover how Pepper Bio's cutting-edge approach could redefine the future of treatment.

Highlights:

•  Discussion on the challenges of transomics in disease study and the significance of quality data in distinguishing viable signals from biological "noise."
•  Insight into the role of transomics in offering a multi-layered analysis of diseases, which could potentially lead to identifying novel targets for difficult-to-treat conditions.
• Addresses the need for quality data in AI-driven research, emphasizing Pepper Bio's success in identifying viable drug targets with a high rate of in vivo validation.